Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): A randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Author(s): Monk, BJ; Poveda, A; Vergote, I; Raspagliesi, F; Fujiwara, K; Bae, DS; Oaknin, A; Ray-Coquard, I; Provencher, DM; Karlan, BY; Lhomme, C; Richardson, G; Rincon, DG; Coleman, RL; Herzog, TJ; Marth, C; Brize, A; Fabbro, M; Redondo, A; Bamias, A; Tassoudji, M; Navale, L; Warner, DJ; Oza, AM